Jonathan Zorea
Beersheba, D 84105, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Cargo-Dependent Targeted Cellular Uptake Using Quaternized Starch as a Carrier.
Journal: Nanomaterials (Basel, Switzerland)
Published: May 15, 2023
TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 07, 2023
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.
Journal: Molecular oncology
Published: October 26, 2022
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer.
Journal: Cancer research
Published: August 16, 2022
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
Journal: Journal for immunotherapy of cancer
Published: February 06, 2022
Cell stiffness predicts cancer cell sensitivity to ultrasound as a selective superficial cancer therapy.
Journal: Bioengineering & translational medicine
Published: December 25, 2020
Surface roughness-induced absorption acts as an ovarian cancer cells growth sensor-monitor.
Journal: Biosensors & bioelectronics
Published: January 30, 2020
Probing antibody surface density and analyte antigen incubation time as dominant parameters influencing the antibody-antigen recognition events of a non-faradaic and diffusion-restricted electrochemical immunosensor.
Journal: Analytical and bioanalytical chemistry
Published: November 21, 2019
Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy.
Journal: JCI insight
Published: March 13, 2019
Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy.
Journal: Frontiers in oncology
Published: October 18, 2018
Last Updated: 09/26/2026